Header Logo

Connection

Daniel Schultz to Humans

This is a "connection" page, showing publications Daniel Schultz has written about Humans.
Connection Strength

0.092
  1. Carbohydrate-Small Molecule Hybrids as Lead Compounds Targeting IL-6 Signaling. Molecules. 2023 Jan 09; 28(2).
    View in: PubMed
    Score: 0.048
  2. Development of Novel Indole-Based Covalent Inhibitors of TEAD as Potential Antiliver Cancer Agents. J Med Chem. 2024 Sep 26; 67(18):16270-16295.
    View in: PubMed
    Score: 0.014
  3. Computer-Aided Design and Biological Evaluation of Diazaspirocyclic D4R Antagonists. ACS Chem Neurosci. 2024 Jun 19; 15(12):2396-2407.
    View in: PubMed
    Score: 0.013
  4. Design and evaluation of novel analogs of 2-amino-4-boronobutanoic acid (ABBA) as inhibitors of human gamma-glutamyl transpeptidase. Bioorg Med Chem. 2022 11 01; 73:116986.
    View in: PubMed
    Score: 0.012
  5. Stromal cell-free conditions favorable for human B lymphopoiesis in culture. J Immunol Methods. 2010 Jul 31; 359(1-2):47-55.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.